Robert Beardsley

Have worn many hats within Galera – now a publicly listed biotech company – serving as co-Founder, Chair, CEO, and board member before moving into Exec Chair & (now) COO roles. The consistent focus in these roles has been to drive growth and innovation by shaping strategy, securing funding, leading R&D, expanding market opportunity and extending market exclusivity. Have managed 30+ cross-functional specialists, coached executives, ensured business-wide buy-in for the overall mission of improving outcomes for cancer patients, and continually improved development, clinical and commercial areas. ◼️ Drove Galera’s start-up and success by executing leading-edge strategy, creating a robust business environment, and delivering change, including recruiting a CEO for succession planning and building core functional areas from the ground-up, including people, processes, and systems. ◼️Accelerated business growth by designing development path for lead candidate and successfully co-managing execution from selection through pending NDA submission, securing patents and extending market exclusivity for that asset, and discovering and rebranding second candidate, resulting in a combined $150m raised through seed, Series A and B, and crossover Series C fundraising rounds. ◼️ Worked closely with CEO and CBO to secure $117M in royalty deals facilitating Phase 3 trial, and timely $60m IPO against challenging conditions that saw contemporary IPOs pulled. ◼️ Collaborated with leading academic researchers and corporate partners identifying new technology applications and dramatically expanding product market opportunities. ◼️ Spearheaded crisis management, including the rapid resolution of a clinical hold on Phase 3 during IPO process within 3 months, enabling continuation of both and even securing additional patent coverage.